Form D · Other Health Care
Medsender, Inc.
New York, NY · CIK 0002053890
Offering snapshot reported Jan 29, 2025 · SEC filing
- Reported sold
- $7.49M Offering amount: $7.49M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 29, 2025 | Initial | $7,494,999 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536572
Source: Form D, filed Jan 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jainal Bhuiyan | Director |
| Salman Haque | Director, Executive |
| Zain Qayyum | Director, Executive |
| Matthew Rice | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
447 Broadway Floor 2
New York, NY, 10013
New York, NY, 10013